Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for optic atrophy with demyelinating disease of CNS.
7 publications have been identified in PubMed for optic atrophy with demyelinating disease of CNS. Research spans Review / Meta-Analysis (57%), Case Report / Case Series (29%), and Basic Science / Preclinical (14%).
Kadjo CVCA (2026). [PMID: 42153120](https://pubmed.ncbi.nlm.nih.gov/42153120/). *Med Trop Sante Int*. [Case Report / Case Series]
Biswas V (2026). [PMID: 40550629](https://pubmed.ncbi.nlm.nih.gov/40550629/). *Pract Neurol*. [Case Report / Case Series]
Buijze MSJ (2026). [PMID: 42048775](https://pubmed.ncbi.nlm.nih.gov/42048775/). *Mult Scler Relat Disord*. [Review / Meta-Analysis]
Leitner U (2025). [PMID: 40773034](https://pubmed.ncbi.nlm.nih.gov/40773034/). *J Neurol*. [Review / Meta-Analysis]
Adibi A (2025). [PMID: 39853938](https://pubmed.ncbi.nlm.nih.gov/39853938/). *CNS Neurosci Ther*. [Review / Meta-Analysis]
Tenembaum S (2025). [PMID: 40145196](https://pubmed.ncbi.nlm.nih.gov/40145196/). *Curr Opin Neurol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:36 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center